Prazosin 2 mg capsule is a generic prescription medicine for oral use, made by 30 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Protect from light and moisture.
Key facts
- Active ingredient (INN)
- Prazosin
- Brand
- Sold under the generic name
- Strength
- 2 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 100 capsules, 250 capsules, 1000 capsules and 73 more
- Manufacturers
- Alembic PharmaceuticalsIndiaNovadoz PharmaceuticalsIndiaAurobindo PharmaIndiaGranules IndiaIndiaLifestar PharmaIndiaBioconIndiaAphena Pharma Solutions - TennesseeANI PharmaceuticalsRemedyrepackExelan Pharmaceuticals30 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Protect from light and moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C02CA01 Prazosin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 February 1989
- Identifiers
- RxCUI 198141, 312593, 312594DailyMed set ID cdde7b22-6b29-4cac-8bd6-f613dab6eef1, d4af73d1-c97e-4418-9e24-007b10af0bd9, 559082c2-4130-a2bc-e063-6294a90ab781 +34NDC 76282-722, 62332-692, 87441-068 +34Application ANDA214608, ANDA217268, ANDA213052 +8
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 30 labelers. The register lists 76 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 capsule in 1 bottle | 46708-692-31 | Alembic PharmaceuticalsIndia | 9 March 2023 |
| 250 capsule in 1 bottle | 46708-692-61 | Alembic PharmaceuticalsIndia | 9 March 2023 |
| 1000 capsule in 1 bottle | 46708-692-91 | Alembic PharmaceuticalsIndia | 9 March 2023 |
| 100 capsule in 1 bottle | 62332-692-31 | Alembic PharmaceuticalsIndia | 9 March 2023 |
| 250 capsule in 1 bottle | 62332-692-61 | Alembic PharmaceuticalsIndia | 9 March 2023 |
| 1000 capsule in 1 bottle | 62332-692-91 | Alembic PharmaceuticalsIndia | 9 March 2023 |
| 100 capsule in 1 bottle | 59651-272-01 | Aurobindo PharmaIndia | 31 March 2023 |
| 1000 capsule in 1 bottle | 59651-272-99 | Aurobindo PharmaIndia | 31 March 2023 |
| 100 capsule in 1 bottle | 70377-067-11 | BioconIndia | 9 January 2023 |
| 100 capsule in 1 bottle | 70010-085-01 | Granules IndiaIndia | 3 January 2022 |
| 1000 capsule in 1 bottle | 70010-085-10 | Granules IndiaIndia | 3 January 2022 |
| 100 capsule in 1 bottle | 70756-430-11 | Lifestar PharmaIndia | 3 January 2023 |
| 1000 capsule in 1 bottle | 70756-430-12 | Lifestar PharmaIndia | 3 January 2023 |
| 100 capsule in 1 bottle | 72205-276-91 | Novadoz PharmaceuticalsIndia | 16 April 2025 |
| 250 capsule in 1 bottle | 72205-276-95 | Novadoz PharmaceuticalsIndia | 16 April 2025 |
| 1000 capsule in 1 bottle | 72205-276-99 | Novadoz PharmaceuticalsIndia | 16 April 2025 |
| 100 capsule in 1 bottle | 70954-020-10 | ANI Pharmaceuticals | 3 October 2018 |
| 1000 capsule in 1 bottle | 70954-020-20 | ANI Pharmaceuticals | 3 October 2018 |
| 100 blister pack in 1 carton / 1 capsule in 1 blister pack | 70954-020-40 | ANI Pharmaceuticals | 13 April 2021 |
| 100 capsule in 1 bottle | 76282-722-01 | Exelan Pharmaceuticals | 17 January 2023 |
| 1000 capsule in 1 bottle | 76282-722-10 | Exelan Pharmaceuticals | 17 January 2023 |
| 100 capsule in 1 bottle | 0527-4181-37 | Lannett | 3 January 2024 |
| 1000 capsule in 1 bottle | 0527-4181-43 | Lannett | 3 January 2024 |
| 100 blister pack in 1 carton / 1 capsule in 1 blister pack | 51079-631-20 | Mylan Institutional | 6 October 1998 |
| 100 capsule in 1 bottle, plastic | 0378-2302-01 | Mylan Pharmaceuticals | 28 February 1989 |
| 1000 capsule in 1 bottle, plastic | 0378-2302-10 | Mylan Pharmaceuticals | 28 February 1989 |
| 100 capsule in 1 bottle | 0093-4068-01 | Teva Pharmaceuticals | 22 February 2007 |
| 1000 capsule in 1 bottle | 0093-4068-10 | Teva Pharmaceuticals | 22 February 2007 |
| 30 capsule in 1 bottle | 71610-694-30 | Aphena Pharma Solutions - Tennessee | 17 March 2023 |
| 60 capsule in 1 bottle | 71610-694-53 | Aphena Pharma Solutions - Tennessee | 17 March 2023 |
| 90 capsule in 1 bottle | 71610-694-60 | Aphena Pharma Solutions - Tennessee | 17 March 2023 |
| 180 capsule in 1 bottle | 71610-694-80 | Aphena Pharma Solutions - Tennessee | 17 March 2023 |
| 90 capsule in 1 bottle | 71610-980-60 | Aphena Pharma Solutions - Tennessee | 13 January 2026 |
| 180 capsule in 1 bottle | 71610-980-80 | Aphena Pharma Solutions - Tennessee | 13 January 2026 |
| 90 capsule in 1 bottle | 71610-981-60 | Aphena Pharma Solutions - Tennessee | 13 January 2026 |
| 180 capsule in 1 bottle | 71610-981-80 | Aphena Pharma Solutions - Tennessee | 13 January 2026 |
| 100 pouch in 1 box / 1 capsule in 1 pouch | 70518-2178-2 | Remedyrepack | 28 March 2023 |
| 30 capsule in 1 blister pack | 70518-3679-0 | Remedyrepack | 12 March 2023 |
| 30 capsule in 1 blister pack | 70518-4263-0 | Remedyrepack | 23 January 2025 |
| 30 capsule in 1 bottle | 71335-1085-1 | Bryant Ranch Prepack | 1 February 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 23 June 1976 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Prazosin
Clinical summary
Prazosin is an alpha-adrenergic blocker indicated for the treatment of hypertension, to lower blood pressure. It is available as capsules for oral use. MedsAcross supplies Prazosin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PrazosinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Prazosin Hydrochloride prescribing information (Prasco Laboratories) · U.S. National Library of Medicine, DailyMed
Need Prazosin 2 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.